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ABSTRACT
Objective: This study aimed to establish the clinical
characteristics of patients with glaucoma attending eye
care facilities in Botswana, and management of glaucoma
among patients who received care in these facilities.
The study also aimed to calculate the number of new
diagnoses of glaucoma within the glaucoma service.
Design: A prospective, hospital-based, observational
study.
Setting: A multicentre study was undertaken in
government-run eye departments in Botswana from June
to August 2012.
Participants: All patients with a diagnosis of glaucoma
attending clinics at seven study sites were invited to
participate.
Outcome measures: Examination findings, diagnosis
and management were extracted from individual patient-
held medical charts. Sociodemographic characteristics,
patient knowledge and understanding of glaucoma were
assessed through face-to-face interviews. In addition,
details of outpatient attendances for 2011 were collected
from 21 government-run hospitals.
Results: The majority of the 366 patients interviewed
had a diagnosis of primary glaucoma (86.6%). The
diagnoses were mainly made by ophthalmologists
(48.6%) and ophthalmic nurses (44.0%). Many patients
(38.5%) had been symptomatic for over 6 months before
visiting an eye clinic. The mean presenting intraocular
pressure was 28.2 mm Hg (SD 11.9 mm Hg). Most
follow-up patients (79.2%) had not received surgery,
however, many (89.5%) would accept surgery. Only
11.5% of participants had heard of glaucoma prior to
diagnosis. Many participants (35.9%) did not understand
glaucoma after being diagnosed. The majority (94.9%) of
living first-degree relatives had never been examined. The
number of newly diagnosed glaucoma cases for 2011 in
the south of the country was 14.1/100 000; 95% CI
(12.0 to 16.5), in the north it was 16.2/100 000; 95% CI
(13.8 to 19.0).
Conclusions: Glaucoma is a significant burden that
presents challenges to ophthalmic services in Botswana.
Many patients have limited understanding of the
condition and poor access to services. There is a need to
develop a treatment infrastructure to include safe surgery
and a reliable supply of effective medication.
BACKGROUND
Glaucoma is a signiﬁcant cause of visual
impairment, estimated to be responsible for
8% of blindness throughout the world.1 It is
also a major cause of blindness in Africa,2–5
with black populations having the highest
prevalence of primary open-angle glaucoma
(POAG).6–8
Studies in other sub-Saharan countries
have shown that POAG is the most common
form of glaucoma.2–5 The disease tends to
Strengths and limitations of this study
▪ The study recruited a large number of patients
from a sparsely populated country where the
number of patients with glaucoma being managed
by the eye service is unknown.
▪ This study provided detailed demographic and clin-
ical data from a previously uninvestigated patient
population where individual patient records are not
kept.
▪ The weakness of the study is that it is hospital
based rather than population based, which will
be limited in reflecting the true population when
guiding service development.
▪ Limited availability of sensitive diagnostic equip-
ment and the reliance on ophthalmic nurses will
lead to inaccuracy in the diagnosis and classifi-
cation of glaucoma.
▪ The reliance on often incomplete medical records
and collection of historical information from
patient interview will introduce error in the data
collected.
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have an earlier onset, and the progression rate may also
be faster in these populations.9 10
There are signiﬁcant challenges with diagnosis and
management of glaucoma in the developing world.
Many patients have poor access to healthcare facilities
and receive inadequate follow-up care.11–18 The problem
is considerably aggravated by poor awareness of glau-
coma among the population leading to late presenta-
tion,19–25 and limited treatment options once they are
diagnosed with the disease.
Botswana is a middle-income African country with an
estimated population of 2.24 million.26 There is limited
access to ophthalmic care, with only two ophthalmolo-
gists working in the public sector during the data collec-
tion period. There have been no previous studies
investigating glaucoma in Botswana and very little infor-
mation is available regarding glaucoma burden and its
management strategies in the country.
This study, ﬁrst, aimed to investigate the characteristics
of patients with glaucoma in Botswana through describing
the type of glaucoma and presenting symptoms; determin-
ing how glaucoma is managed in these patients; establish-
ing prior awareness of glaucoma; and exploring
understanding of glaucoma after diagnosis. Second, the
study attempted to estimate the number of new diagnoses
of glaucoma within these eye facilities for 2011.
METHODS
Data collection
Patient interviews were conducted by the principal
investigators in seven government-run institutions
over a 7-week period (18 June–3 August 2012). The
institutions consisted of the two tertiary referral
centres: Princess Marina Hospital (PMH) and Sekgoma
Memorial Hospital (SMH); a referral hospital:
Nyangabgwe; district hospitals: Kanye, Mahalapye,
Palapye; and primary hospitals: Letlhakane, Palapye.
Study site selection was based on which eye depart-
ments see the most patients.
At the time of the study, there were two ophthalmolo-
gists working in the government sector, one based at
each tertiary referral centre. The referral centre for the
south is PMH; the one for the north is SMH. The major-
ity of eye clinics, including the two tertiary centres, did
not keep registers of the number of patients with glau-
coma. In addition, there were no records of referral
sources in either of the tertiary hospitals. Hospitals kept
records of the number of consultations by diagnosis and
whether a consultation was a new or repeat visit.
Individual patient records were not kept at the hospitals.
Instead, patients brought a card detailing diagnosis,
examination ﬁndings and treatment when attending an
appointment. These patient-held cards are taken to out-
patient clinic appointments at all hospitals and are the
only record of the details of a consultation.
A drop-in service was organised by every government
eye clinic, whereby patients attended to be treated
within the eye clinic or referred to either PMH or SMH
to see an ophthalmologist. There were no referral guide-
lines and there was no deﬁned referral pathway.
All patients with a diagnosis of glaucoma attending an
outpatient clinic at one of the study sites were invited to
participate and were interviewed using a structured ques-
tionnaire. There was no active recruitment or advertising.
The questionnaire was designed by the authors of the
study and translated into Setswana and subsequently back-
translated. It was then piloted on 12 patients attending
clinic at PMH prior to data collection and adjustments
were made on the basis of the response obtained.
Interviews were conducted in English or Setswana with the
help of an interpreter. Diagnosis of glaucoma was made
through patient history and examination. The examin-
ation of patients varied between clinics, depending on
equipment available and expertise of ophthalmic staff. All
patients who participated in the survey had their diagnosis
of glaucoma conﬁrmed by an ophthalmologist at a point
after their diagnosis. Data collected in these interviews
included sociodemographic characteristics, history, family
history, diagnosis, treatment, prior awareness of glaucoma,
information received after diagnosis and referral sources.
Information on presenting complaint and duration of pre-
senting complaint at ﬁrst presentation that led to the diag-
nosis of glaucoma was collected from patient held records
if it had been recorded, or collected from the patient if
not recorded in the patient ﬁle. Past medical history was
assessed by inspecting the patient record ﬁle for con-
ﬁrmed diagnoses of hypertension, diabetes, myopia, eye
injury, previous trauma, previous eye surgery, migraine and
steroid use. The patients were also asked if they knew that
they suffered from such problems. Family history was
assessed by checking medical cards for any details and
asking if any member of that patient’s family was diag-
nosed with glaucoma or if any member of that patient’s
family was blind. Current understanding of glaucoma was
assessed by asking patients what they understood of glau-
coma. A patient was deemed to understand glaucoma if
they gave answers such as “glaucoma is high pressure in
the eye/damages the nerve/is an eye condition that could
lead to blindness/may need treatment for life.” Screening
of relatives was assessed by asking patients if any of their
family members had ever been checked for glaucoma or if
any of their family members had ever been to an eye
clinic. Information on examination ﬁndings, management
and history were obtained from patients’ medical cards.
In the second aspect of the study, the total number of
new and follow-up glaucoma visits was collected from
clinic logbooks in 21 centres for each month of 2011 to
estimate the number of newly diagnosed patients within
the glaucoma service for that year. The study sites con-
sisted of the two eye referral centres with the remaining
sites being primary and district hospitals. The selection
criteria for the government hospitals were any institution
with a functional eye unit as determined by the Ministry
of Health. At the time of study, there were 27 govern-
ment eye units; 6 declined to participate.
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Data management and analysis
Data were entered in Microsoft Excel worksheets and
analysis undertaken using Stata V.9.2 (Stata
Corporation, College Station, Texas, USA). Data were
explored using cross-tabulations and frequency distribu-
tions. Visual acuity was classiﬁed based on the WHO cat-
egories of visual impairment. Severe impairment was
deﬁned as visual acuity of less than 6/60 but greater
than or equal to 3/60. Moderate impairment was deﬁned
as visual acuity of less than 6/18 but equal to or greater
than 6/60 in the better eye. Normal vision was deﬁned to
represent persons who had normal or near-normal
vision in the better eye (VA ≥6/18). Blindness or visual
impairment due to ﬁeld restriction was not included
due to lack of regular visual ﬁeld testing. The number of
newly diagnosed cases of glaucoma in Botswana in 2011
per unit population was calculated for PMH as well as
SMH by dividing the number of patients with newly diag-
nosed glaucoma by the catchment population served by
each referral hospital. CIs were estimated using bino-
mial exact method. An assumption was made that most
district and primary hospitals refer patient with newly
diagnosed glaucoma to either SMH or PMH. Written
informed consent was sought and obtained from all
patients participating in the study.
RESULTS
Demographic characteristics
A total of 366 patients participated in the glaucoma
survey. Ninety-eight per cent of patients participated.
The demographic characteristics of the glaucoma survey
participants are summarised in table 1. The majority of
the patients were female (52.5%), aged 60 years and
above (62.3%) and 24.2% had no formal education.
The mean age was 62 years (SD 17.2 years).
Presenting symptoms, duration and medical history
Table 2 summarises the presenting symptoms and its
history among glaucoma survey participants. The most
common presenting symptom at ﬁrst presentation was
poor vision (66.4%). Many cases were detected inciden-
tally through routine check-up. Other symptoms on pres-
entation included red or itchy eyes, headache, pain and
tearing. A signiﬁcant proportion of patients (38.5%)
waited over 6 months from the beginning of their
symptom before visiting an eye clinic. The majority of
patients (51.1%) had visited an eye clinic other than the
one they attended when interviewed. Many (37.1%) had a
known family history and 30.3% of patients had a ﬁrst-
degree relative diagnosed with glaucoma. Fourteen partici-
pants had one or more family members with signiﬁcantly
impaired vision of unknown cause. Based on the WHO
categories of visual impairment, 13.7% of the patients
interviewed were blind and 53.6% had normal or near
normal vision. Blindness was deﬁned as a visual acuity of
less than 3/60 in the better eye. Many (22.3%) patients
had a travel time of over 1 h to visit an eye clinic.
Table 1 Demographic characteristics of glaucoma survey
participants
Characteristic Number of patients (%)
Sex
Male 174 (47.5)
Female 192 (52.5)
Age
0–19 14 (3.8)
20–29 4 (1.1)
30–39 24 (6.6)
40–49 36 (9.8)
50–59 58 (15.8)
60–69 92 (25.1)
70–79 86 (23.5)
>79 50 (13.7)
Unknown 2 (0.5)
Education
None 88 (24.2)
Primary 178 (48.9)
Secondary 64 (17.6)
Graduate/postgraduate 34 (9.3)
Marital status
Single 125 (34.4)
Married 154 (42.4)
Divorced 9 (2.5)
Widowed 74 (20.4)
Separated 1 (0.3)
Table 2 Summary of presenting symptoms, duration and
medical history among patients with glaucoma
Characteristics Number of patients (%)
Presenting symptom
None 20 (5.5)
Poor vision 243 (66.4)
Inability to read 31 (8.5)
Bumping into objects 15 (4.1)
Other 74 (20.2)
Duration
<6 months 225 (61.5)
>6 months 141 (38.5)
Medical history
Hypertension 187 (51.1)
Diabetes 44 (12.0)
Myopia 115 (31.4)
Eye injury 59 (16.1)
Previous eye surgery 114 (31.1)
Migraine 132 (36.1)
Steroid use 60 (16.4)
Travel taken (h) (n=359)
Less than 0.5 211 (58.8)
Between 0.5 and 1 68 (18.9)
Greater than 1 80 (22.3)
Visits to other hospitals 187 (51.1)
Number with family history 128 (37.1)
Visual acuity
Normal vision 196 (53.6)
Moderate impairment 76 (20.8)
Severe impairment 39 (10.7)
Blind 50 (13.7)
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Diagnosis and management of glaucoma
Table 3 summarises the cadre of eye-care practitioners
diagnosing glaucoma, type of glaucoma and manage-
ment of the participants. The majority of initial diagno-
ses were made by ophthalmologists (48.6%) and
ophthalmic nurses (44.0%). The vast majority of cases
were due to primary glaucoma (86.6%). Secondary glau-
coma types included: phacomorphic, congenital, pig-
mentary, uveitic, neovascular and traumatic glaucoma.
The most common medications used were levobunolol
(72.7%) and brimonidine (59%). Most patients (79.2%)
did not have surgery to treat glaucoma. A minority
(6.0%) had not received either surgical or medical treat-
ment. Every patient interviewed reported difﬁculty in
obtaining medications from government hospitals and
had to either buy medication through private facilities
or wait for medications to become available.
From the patient-held medical card, presenting intrao-
cular pressure (IOP) was recorded in 204 participants. Of
those, 175 (85.8%) had an IOP of greater than 21 mmHg
in one or both eyes at ﬁrst presentation. The mean pre-
senting IOP was 28.2 mm Hg (SD 11.9 mmHg); the
median presenting IOP was 25 mmHg. Current vertical
cup/disc ratio (CDR) was recorded from 144 participants;
133 (92.4%) had a CDR of 0.6 or above in at least one eye.
Patients’ knowledge of glaucoma before and after
diagnosis
Table 4 summarises the participants’ awareness and knowl-
edge of glaucoma before diagnosis and after diagnosis.
Only 11.5% of the participants had heard of glaucoma
prior to being diagnosed. Many participants (35.9%) did
not understand glaucoma after being diagnosed.
Screening of relatives for glaucoma
The screening of living ﬁrst-degree relatives of patients
with primary glaucoma is shown in table 5. The vast major-
ity of living relatives (94.9%) have never been examined
for glaucoma. The highest proportion of relatives checked
was parents of patients with glaucoma (11.1%).
Number of newly diagnosed cases of glaucoma
The number of new glaucoma cases at PMH in 2011 was
157. PMH serves a catchment population of 1 114 589;
therefore the number of newly diagnosed cases of glau-
coma in the south of the country was 14.1/100 000; 95%
CI (12.0 to 16.5). The number of new glaucoma cases at
SMH in 2011 was 154. SMH serves a population of
949 312, thus the number of newly diagnosed cases of
glaucoma in the north of the country is 16.2/100 000;
95% CI (13.8 to 19.0). There was no statistically signiﬁ-
cant difference in the number of new cases diagnosed
in the south compared to the north (p value=0.2).
Table 3 Summary of diagnosis, glaucoma type and
management of glaucoma
Characteristic Number of patients (%)
Diagnosed by
Ophthalmologist 178 (48.6)
Ophthalmic nurse 161 (44.0)
Other doctor 13 (3.6)
Optometrist 10 (2.7)
Unknown 4 (1.1)
Glaucoma type
Primary 317 (86.6)
Secondary 30 (8.2)
Unknown 19 (5.19)
Anterior chamber angle
Open angle 316 (86.3)
Angle closure 2 (0.5)
Unknown 48 (13.1)
Eye affected
Right eye only 21 (5.7)
Left eye only 34 (9.3)
Both eyes 287 (78.4)
Unknown 24 (6.6)
Medication
Brimonidine 216 (59.0)
Levobunolol 266 (72.7)
Pilocarpine 138 (37.7)
Acetazolamide 59 (16.1)
Latanoprost 3 (0.8)
Oxymetazoline 2 (0.5)
No medication 26 (7.1)
Glaucoma surgery
Yes 77 (21.1)
No 289 (79.2)
No treatment 22 (6.0)
Table 4 Summary of patients’ knowledge of glaucoma
before and after diagnosis
Knowledge
Number of
patients (%)
Before diagnosis
Number who had heard of glaucoma
(N=366)
42 (11.5)
Of those who have heard of glaucoma (N=42)
Number aware that it can cause vision
loss
30 (71.4)
Number who believed vision loss from
glaucoma can be reversed
19 (45.2)
Number aware it could run in families 23 (54.8)
Number aware of the need for lifelong
treatment
31 (73.8)
Number who would accept an offer of
surgery (N=366)
323 (89.5)
Number who have taken traditional
medication for their eyes (N=366)
32 (8.8)
After diagnosis
Number who understand glaucoma
(N=366)
229 (64.1)
Of those who understood (N=229)
Number briefed 213 (93.0)
Number who had received leaflet 26 (11.4)
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DISCUSSION
This study aimed to explore the characteristics of
patients with glaucoma and how these patients were
managed by the eye services in Botswana. The study
revealed that: the majority of patients had primary glau-
coma; diagnoses were mainly made by ophthalmologists
and ophthalmic nurses; the majority of patients did not
undergo surgical treatment; few patients understood
glaucoma before and after diagnosis; and the majority of
living ﬁrst-degree relatives had never been screened for
glaucoma. The number of newly diagnosed cases of
glaucoma in the south of the country was 14.1/100 000;
95% CI (12.0 to 16.5), in the north it was 16.2/100 000;
95% CI (13.8 to 19.0).
There are several limitations of the study. A hospital-
based as opposed to a population-based study is subject
to bias as attendance at such clinics is dependent on
several variables such as education, transport, wealth,
previous experience and family history. Therefore, the
sample is not representative of the whole population as
only the patients who sought help were interviewed. The
absence of comprehensive hospital records caused difﬁ-
culty in estimating numbers of patients with glaucoma
and has resulted in several challenges to the eye-care ser-
vices within the country. Additionally, the records
brought to the clinics by individual patients were often
incomplete and patients could not always give a clear
description of events. Certain examination ﬁndings, for
example, CDR, were not being recorded by ophthalmic
staff in the patient-held notes. Such historical data col-
lected from patient interviews can be inaccurate, poten-
tially leading to errors in presenting symptom, duration,
medical history and family history. The introduction of
standardised patient ﬁles to the eye services of Botswana
may encourage consistent completion of important
details during an eye consultation. Over half (51.1%) of
patients had visited more than one hospital for their eye
conditions, therefore incomplete glaucoma registers and
lack of referral records may make follow-up particularly
difﬁcult as patients become ‘lost’ in the system.
Six units did not participate; these were small primary
hospitals that we have been told to see a small number
of patients with glaucoma compared with the clinics
included in the study. We understand that most of their
patients with glaucoma are referred to tertiary centres,
therefore we anticipate the missing data from these
small centres had a small effect on the results and on
our calculation of the number of new diagnoses within
the glaucoma service.
Many patients were unaware of glaucoma before diagno-
sis, and those who did had a limited understanding of the
disease, which is similar to ﬁndings in other African coun-
tries.27–34 Indeed, 66.4% of patients had poor vision as
their presenting symptom and 38.5% of patients were
symptomatic for over 6 months before seeking help, sug-
gesting that many of these patients are presenting late and
only after signiﬁcant visual loss has occurred. Public aware-
ness campaigns could be used to highlight glaucoma as a
signiﬁcant and silent cause of blindness. Previous studies
have identiﬁed a number of successful ways to deliver and
communicate effective health education, mainly through
media outlets such as radio and television.35 The disadvan-
tages of such programmes would be the implementation,
cost and the need to divide such resources for other
health problems of considerable importance in the
country, where awareness is limited. A large proportion of
patients diagnosed did not understand the disease and the
aims of medical therapy after diagnosis, which leads to
incorrect administration of medication and poor compli-
ance. Basic education schemes have been used elsewhere
to increase patients’ knowledge and such programmes
may also manage expectations of glaucoma therapy.36
Such schemes could be used in Botswana to assist in teach-
ing correct administration of eye drops and improving
compliance with medical therapy.
Large numbers of at risk family members were not
checked for primary glaucoma, therefore large numbers
of people in this at-risk group may unknowingly have the
disease. The reasons for this include lack of awareness of
the disease and poor access to ophthalmic services.
Community eye outreach programmes have had success
in detecting glaucoma in earlier stages in some African
countries,37 although screening programmes are still of
unproven beneﬁt. Botswana is a sparsely populated
country, therefore, any future service development must
include a robust outreach scheme to remote areas.
There is limited availability of medications and almost
complete lack of prostaglandin drugs. A large propor-
tion (21.1%) of the patients interviewed had received
glaucoma surgery. The vast majority were trabeculect-
omy; many were unaugmented as antimetabolites were
only available at PMH and were frequently out of stock.
Of the 77 patients who had surgery, 70 were using
topical medication suggesting a suboptimal outcome. In
2011, a total of 3099 ophthalmic operations were under-
taken across six government-run hospitals. Only 0.8% of
these were glaucoma operations. The large proportion
of patients having had glaucoma surgery in our study
could be due to this subgroup of patients being more
proactive and therefore more likely to attend follow-up
or having better access to eye clinics. Alternatively, some
patients had seen private ophthalmologists in Botswana
or abroad, mainly in South Africa. There were four
ophthalmologists working in the private sector, three in
Gaborone and one in Francistown.
Table 5 Examination of living relatives of patients with
primary glaucoma
Relation Total living relatives Screened (%)
Brothers 449 26 (5.8)
Sisters 491 23 (4.7)
Parents 108 12 (11.1)
Sons 638 28 (4.4)
Daughters 638 29 (4.5)
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Surgery as a ﬁrst-line intervention has been advocated
in other African countries.11 38 However, it is believed
that patients are likely to refuse ocular surgery due to
rumours of failed surgeries within small communities39
and because glaucoma surgery is associated with appre-
ciable risk and will not improve vision. Interestingly, the
majority of patients interviewed in Botswana would con-
sider surgery to treat their glaucoma, which if they went
through with it, is a higher acceptance rate than has been
found in some other studies.40 A safe and cost-effective
treatment where the majority of follow-ups could be per-
formed by mid-level eye-care workers would be ideal.
Selective Laser Trabeculoplasty (SLT) has been advocated
as a primary treatment for open-angle glaucoma41 and
there is evidence that shows efﬁcacy of SLT as either an
adjunct or an alternative to medical therapy where access
to medications or compliance is a problem.42
The majority of patients had a diagnosis of primary
glaucoma, which has been shown to be the main type of
glaucoma in African populations.2–5 However, the
number of angle closure glaucoma diagnoses made by
the ophthalmic staff may be an underestimate due to
lack of gonioscopic lenses in certain eye clinics. At the
time of the study, functioning goniscopic lenses were
only present in PMH and Nyangabgwe. This is of
concern as angle closure has been shown to have a
prevalence of 0.5–1.0% in similar populations.4 43
A large proportion (44%) of patients with glaucoma in
the study were originally diagnosed by ophthalmic
nurses. While these patients had been referred to an
ophthalmologist to have the diagnosis veriﬁed, there are
some clinics that do not routinely refer all patients with
glaucoma/glaucoma-suspect to an ophthalmologist. In
addition, only three clinics had visual ﬁeld analysers and
ﬁve clinics were without tonometers. IOP was usually
measured using Schiotz or non-contact air puff ton-
ometers; one clinic had a Goldmann applanation ton-
ometer. The lack of sensitive diagnostic equipment and
reliance on unsupported ophthalmic nurses to make
initial diagnoses will likely mean a proportion of patients
in the glaucoma service have been misdiagnosed.
There is a lack of reliable epidemiological data on the
incidence and prevalence of glaucoma in Africa. The
prevalence in Botswana is unlikely to be very different
from the two population-based studies in Tswana popula-
tions of South Africa of similar ethnicity. The adjusted
prevalence was 2.9%4 43 for POAG and 2% for second-
ary glaucoma.4 Interestingly, a diagnosis of secondary
glaucoma was given to only 8.2% of the patients in our
sample, suggesting that it may be unrecognised or mis-
diagnosed as primary glaucoma.
The number of newly diagnosed glaucoma cases in
Botswana is likely to be an underestimate of the inci-
dence. This is partly because some peripheral clinics did
not refer all patients with newly diagnosed glaucoma or
glaucoma suspect to the referral centres. There will also
be a number of patients referred who do not attend
appointments at either tertiary centre. Glaucoma is
usually asymptomatic in the early disease stages and
therefore this study will miss these patients who will not
present to eye clinics. Many family members of patients
with glaucoma had not been checked, raising the possi-
bility that the true burden of glaucoma is much higher
than estimated in Botswana, with many patients unknown
to the eye care services. Indeed, conservative estimates of
the annual incidence of glaucoma in other African coun-
tries have been higher at approximately 400 cases per 1
million of the population.11 This suggests the true annual
incidence of glaucoma could be double what is being
diagnosed by the glaucoma services in Botswana.
Conclusions from this study must be interpreted cau-
tiously. Glaucoma is a challenge to the eye services in the
country, as some patients have poor access to services,
limited awareness and understanding of the disease, and
limited treatment options from the resources available.
Further research into the incidence and prevalence of
glaucoma in Botswana is required, as well as the need to
establish effective treatments in eye health service.
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